Nevro (NVRO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Nevro Revenue Highlights

Latest Revenue (Y)

$425.17M

Latest Revenue (Q)

$104.16M

Main Segment (Y)

Painful Diabetic Neuropathy

Main Geography (Y)

UNITED STATES

Nevro Revenue by Period

Nevro Revenue by Year

Date	Revenue	Change
2023-12-31	-	4.63%
2022-12-31	-	5.03%
2021-12-31	-	6.87%
2020-12-31	-	-7.23%
2019-12-31	-	0.77%
2018-12-31	-	18.56%
2017-12-31	-	42.96%
2016-12-31	-	228.28%
2015-12-31	-	113.69%
2014-12-31	-	38.61%
2013-12-31	-	29.48%
2012-12-31	-	-

Nevro generated $425.17M in revenue during NA 2023, up 4.63% compared to the previous quarter, and up 109.78% compared to the same period a year ago.

Nevro Revenue by Quarter

Date	Revenue	Change
2024-06-30	-	2.22%
2024-03-31	-	-12.29%
2023-12-31	-	11.86%
2023-09-30	-	-4.55%
2023-06-30	-	12.96%
2023-03-31	-	-15.39%
2022-12-31	-	13.32%
2022-09-30	-	-3.60%
2022-06-30	-	18.64%
2022-03-31	-	-14.52%
2021-12-31	-	10.25%
2021-09-30	-	-8.92%
2021-06-30	-	15.48%
2021-03-31	-	-19.25%
2020-12-31	-	1.17%
2020-09-30	-	92.34%
2020-06-30	-	-35.53%
2020-03-31	-	-23.53%
2019-12-31	-	14.19%
2019-09-30	-	7.04%
2019-06-30	-	13.91%
2019-03-31	-	-23.90%
2018-12-31	-	12.88%
2018-09-30	-	-0.47%
2018-06-30	-	9.64%
2018-03-31	-	-10.54%
2017-12-31	-	19.10%
2017-09-30	-	5.43%
2017-06-30	-	13.99%
2017-03-31	-	-2.97%
2016-12-31	-	15.77%
2016-09-30	-	9.97%
2016-06-30	-	33.01%
2016-03-31	-	25.74%
2015-12-31	-	115.06%
2015-09-30	-	34.89%
2015-06-30	-	18.17%
2015-03-31	-	-0.55%
2014-12-31	-	12.08%
2014-09-30	-	15.17%
2014-06-30	-	12.94%
2014-03-31	-	7.55%
2013-12-31	-	-0.03%
2013-09-30	-	-

Nevro generated $104.16M in revenue during Q2 2024, up 2.22% compared to the previous quarter, and up 108.13% compared to the same period a year ago.

Nevro Revenue Breakdown

Nevro Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21
Painful Diabetic Neuropathy	-	-	-

Nevro's latest annual revenue breakdown by segment (product or service), as of Dec 23: Painful Diabetic Neuropathy (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21
Painful Diabetic Neuropathy	-	-	-	-	-	-	-	-	-

Nevro's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Painful Diabetic Neuropathy (100.00%).

Nevro Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Non-US	-	-	-	-	-
UNITED STATES	-	-	-	-	-
Non Us	-	-	-	-	-

Nevro's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (86.21%), and Non-US (13.79%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 18	Sep 18	Jun 18	Mar 18
UNITED STATES	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Us	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Nevro's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (86.57%), and Non-US (13.43%).

Nevro Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	-	-
CNMD	CONMED	-	-
LIVN	LivaNova	-	-
NVRO	Nevro	-	-
GKOS	Glaukos	-	-
FNA	Paragon 28	-	-
KIDS	OrthoPediatrics	-	-
SRDX	Surmodics	-	-
RXST	RxSight	-	-
SGHT	Sight Sciences	-	-
LUNG	Pulmonx	-	-
IRMD	IRadimed	-	-
NPCE	NeuroPace	-	-
CVRX	CVRx	-	-
OSA	ProSomnus	-	-
OFIX	Orthofix Medical	-	-

NVRO Revenue FAQ

What is Nevro’s yearly revenue?

Nevro's yearly revenue for 2023 was $425.17M, representing an increase of 4.63% compared to 2022. The company's yearly revenue for 2022 was $406.36M, representing an increase of 5.03% compared to 2021. NVRO's yearly revenue for 2021 was $386.9M, representing an increase of 6.87% compared to 2020.

What is Nevro’s quarterly revenue?

Nevro's quarterly revenue for Q2 2024 was $104.16M, a 2.22% increase from the previous quarter (Q1 2024), and a -4.27% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $101.9M, a -12.29% decrease from the previous quarter (Q4 2023), and a 5.78% increase year-over-year (Q1 2023). NVRO's quarterly revenue for Q4 2023 was $116.18M, a 11.86% increase from the previous quarter (Q3 2023), and a 2.05% increase year-over-year (Q4 2022).

What is Nevro’s revenue growth rate?

Nevro's revenue growth rate for the last 3 years (2021-2023) was 9.89%, and for the last 5 years (2019-2023) was 8.95%.

What are Nevro’s revenue streams?

Nevro's revenue streams in c 23 are Painful Diabetic Neuropathy

What is Nevro’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Nevro was Painful Diabetic Neuropathy. This segment made a revenue of $77.9M, representing 100.00% of the company's total revenue.